abstract
- Adjuvants that combine TLR agonists and inflammatory agonists promote robust and durable vaccine responses (Bechtold et al. and Arunachalam et al.).
Make it a combo.
Review
Overview
authors
publication date
- July 31, 2024
published in
- Science translational medicine Journal
Research
keywords
- Adjuvants, Immunologic
- Toll-Like Receptors
Identity
Scopus Document Identifier
- 85200292936
Digital Object Identifier (DOI)
- 10.1126/scitranslmed.adq5644
PubMed ID
- 39083583
Additional Document Info
has global citation frequency
volume
- 16
issue
- 758